ALPHAGAN-P Eye Drops 0.15%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALPHAGAN-P Eye Drops 0.15%, covering 2020-12-01 to 2020-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial [Phase 4]